Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Hooper, DC' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 87 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Spitsin, S; Hooper, DC; Leist, T; Streletz, LJ; Mikheeva, T; Koprowski, H
      Inactivation of peroxynitrite in multiple sclerosis patients after oral administration of inosine may suggest possible approaches to therapy of the disease

      MULTIPLE SCLEROSIS
    2. Spitsin, S; Hooper, DC; Mikheeva, T; Koprowski, H
      Uric acid levels in patients with multiple sclerosis: analysis in mono- and dizygotic twins

      MULTIPLE SCLEROSIS
    3. Hooper, DC
      Emerging mechanisms of fluoroquinolone resistance

      EMERGING INFECTIOUS DISEASES
    4. Hooper, DC
      Minimizing potential resistance: The molecular view - A comment on Courvalin and Trieu-Cuot

      CLINICAL INFECTIOUS DISEASES
    5. Hooper, DC
      Mechanisms of action of antimicrobials: Focus on fluoroquinolones

      CLINICAL INFECTIOUS DISEASES
    6. Zachary, KC; Bayne, PS; Morrison, VJ; Ford, DS; Silver, LC; Hooper, DC
      Contamination of gowns, gloves, and stethoscopes with vancomycin-resistantenterococci

      INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
    7. Koprowski, H; Spitsin, SV; Hooper, DC
      Prospects for the treatment of multiple sclerosis by raising serum levels of uric acid, a scavenger of peroxynitrite

      ANNALS OF NEUROLOGY
    8. Scott, GS; Hooper, DC
      The role of uric acid in protection against peroxynitrite-mediated pathology

      MEDICAL HYPOTHESES
    9. Scott, GS; Kean, RB; Southan, GJ; Szabo, C; Hooper, DC
      Effect of mercaptoethylguanidine scavengers of peroxynitrite on the development of experimental allergic encephalomyelitis in PLSJL mice

      NEUROSCIENCE LETTERS
    10. Hanlon, CA; DeMattos, CA; DeMattos, CC; Niezgoda, M; Hooper, DC; Koprowski, H; Notkins, A; Rupprecht, CE
      Experimental utility of rabies virus-neutralizing human monoclonal antibodies in post-exposure prophylaxis

      VACCINE
    11. Morimoto, K; McGettigan, JP; Foley, HD; Hooper, DC; Dietzschold, B; Schnell, MJ
      Genetic engineering of live rabies vaccines

      VACCINE
    12. Scott, GS; Hake, P; Kean, RB; Virag, L; Szabo, C; Hooper, DC
      Role of poly(ADP-ribose) synthetase activation in the development of experimental allergic encephalomyelitis

      JOURNAL OF NEUROIMMUNOLOGY
    13. Ince, D; Hooper, DC
      Mechanisms and frequency of resistance to gatifloxacin in comparison to AM-1121 and ciprofloxacin in Staphylococcus aureus

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    14. Prosniak, M; Hooper, DC; Dietzschold, B; Koprowski, H
      Effect of rabies virus infection on gene expression in mouse brain

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    15. Pulmanausarakul, R; Faber, M; Morimoto, K; Spitsin, S; Weihe, E; Hooper, DC; Schnell, MJ; Dietzschold, B
      Overexpression of cytochrome c by a recombinant rabies virus attenuates pathogenicity and enhances antiviral immunity

      JOURNAL OF VIROLOGY
    16. Hooper, DC; Kean, RB; Scott, GS; Spitsin, SV; Mikheeva, T; Morimoto, K; Bette, M; Rohrenbeck, AM; Dietzschold, B; Weihe, E
      The central nervous system inflammatory response to neurotropic virus infection is peroxynitrite dependent

      JOURNAL OF IMMUNOLOGY
    17. Morimoto, K; Schnell, MJ; Pulmanausahakul, R; McGettigan, JP; Foley, HD; Faber, M; Hooper, DC; Dietzschold, B
      High level expression of a human rabies virus-neutralizing monoclonal antibody by a rhabdovirus-based vector

      JOURNAL OF IMMUNOLOGICAL METHODS
    18. Fournier, B; Truong-Bolduc, QC; Zhang, XM; Hooper, DC
      A mutation in the 5 ' untranslated region increases stability of norA mRNA, encoding a multidrug resistance transporter of Staphylococcus aureus

      JOURNAL OF BACTERIOLOGY
    19. Dietzschold, B; Morimoto, K; Hooper, DC; Smith, JS; Rupprecht, CE; Koprowski, H
      Genotypic and phenotypic diversity of rabies virus variants involved in human rabies: Implications for postexposure prophylaxis

      JOURNAL OF HUMAN VIROLOGY
    20. Hooper, DC
      Mechanisms of action and resistance of older and newer fluoroquinolones

      CLINICAL INFECTIOUS DISEASES
    21. Hooper, DC
      New uses for new and old quinolones and the challenge of resistance

      CLINICAL INFECTIOUS DISEASES
    22. Hooper, DC; Scott, GS; Zborek, A; Mikheeva, T; Kean, RB; Koprowski, H; Spitsin, SV
      Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNSbarrier permeability changes, and tissue damage in a mouse model of multiple sclerosis

      FASEB JOURNAL
    23. Catalano, OA; Hahn, PF; Hooper, DC; Mueller, PR
      Efficacy of percutaneous abscess drainage in patients with vancomycin-resistant enterococci

      AMERICAN JOURNAL OF ROENTGENOLOGY
    24. Spitsin, SV; Scott, GS; Kean, RB; Mikheeva, T; Hooper, DC
      Protection of myelin basic protein immunized mice from free-radical mediated inflammatory cell invasion of the central nervous system by the natural peroxynitrite scavenger uric acid

      NEUROSCIENCE LETTERS
    25. Hooper, DC
      The fluoroquinolones after ciprofloxacin and ofloxacin

      CURRENT CLINICAL TOPICS IN INFECTIOUS DISEASES, VOL 20
    26. Fournier, B; Zhao, XL; Lu, T; Drlica, K; Hooper, DC
      Selective targeting of topoisomerase IV and DNA gyrase in Staphylococcus aureus: Different patterns of quinolone-induced inhibition of DNA synthesis

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    27. Bisognano, C; Vaudaux, P; Rohner, P; Lew, DP; Hooper, DC
      Induction of fibronectin-binding proteins and increased adhesion of quinolone-resistant Staphylococcus aureus by subinhibitory levels of ciprofloxacin

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    28. Ince, D; Hooper, DC
      Mechanisms and frequency of resistance to premafloxacin in Staphylococcus aureus: Novel mutations suggest novel drug-target interactions

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    29. Kean, RB; Spitsin, SV; Mikheeva, T; Scott, GS; Hooper, DC
      The peroxynitrite scavenger uric acid prevents inflammatory cell invasion into the central nervous system in experimental allergic encephalomyelitis through maintenance of blood-central nervous system barrier integrity

      JOURNAL OF IMMUNOLOGY
    30. Champion, JM; Kean, RB; Rupprecht, CE; Notkins, AL; Koprowski, H; Dietzschold, B; Hooper, DC
      The development of monoclonal human rabies virus-neutralizing antibodies as a substitute for pooled human immune globulin in the prophylactic treatment of rabies virus exposure

      JOURNAL OF IMMUNOLOGICAL METHODS
    31. Fournier, B; Aras, R; Hooper, DC
      Expression of the multidrug resistance transporter NorA from Staphylococcus aureus is modified by a two-component regulatory system

      JOURNAL OF BACTERIOLOGY
    32. Fournier, B; Hooper, DC
      A new two-component regulatory system involved in adhesion autolysis, and extracellular proteolytic activity of Staphylococcus aureus

      JOURNAL OF BACTERIOLOGY
    33. Hooper, DC
      Mechanisms of fluoroquinolone resistance

      GRAM-POSITIVE PATHOGENS
    34. Hooper, DC
      Mechanisms of fluoroquinolone resistance

      DRUG RESISTANCE UPDATES
    35. Eisenman, LM; Brothers, R; Tran, MH; Kean, RB; Dickson, GM; Dietzschold, B; Hooper, DC
      Neonatal Borna disease virus infection in the rat causes a loss of Purkinje cells in the cerebellum

      JOURNAL OF NEUROVIROLOGY
    36. Rohrenbeck, AM; Bette, M; Hooper, DC; Nyberg, F; Eiden, LE; Dietzschold, B; Weihe, E
      Upregulation of COX-2 and CGRP expression in resident cells of the Borna disease virus-infected brain is dependent upon inflammation

      NEUROBIOLOGY OF DISEASE
    37. Fournier, B; Gravel, A; Hooper, DC; Roy, PH
      Strength and regulation of the different promoters for chromosomal beta-lactamases of Klebsiella oxytoca

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    38. Morimoto, K; Hooper, DC; Spitsin, S; Koprowski, H; Dietzschold, B
      Pathogenicity of different rabies virus variants inversely correlates withapoptosis and rabies virus glycoprotein expression in infected primary neuron cultures

      JOURNAL OF VIROLOGY
    39. Hooper, DC
      Mode of action of fluoroquinolones

      DRUGS
    40. HOOPER DC
      BACTERIAL TOPOISOMERASES, ANTI-TOPOISOMERASES, AND ANTI-TOPOISOMERASERESISTANCE

      Clinical infectious diseases
    41. PEGUES DA; COLBY C; HIBBERD PL; COHEN LG; AUSUBEL FM; CALDERWOOD SB; HOOPER DC
      THE EPIDEMIOLOGY OF RESISTANCE TO OFLOXACIN AND OXACILLIN AMONG CLINICAL COAGULASE-NEGATIVE STAPHYLOCOCCAL ISOLATES - ANALYSIS OF RISK-FACTORS AND STRAIN TYPES

      Clinical infectious diseases
    42. ROHRENBECKL AM; BETTEL M; HOOPER DC; NYBERG F; EIDEN LE; DIETZSCHOLD B; WEIHEL E
      INDUCTION OF COX-2 AND CGRP EXPRESSION IN THE BRAIN OF BORNA-DISEASE VIRUS-INFECTED RATS - ITS POSSIBLE ROLE IN CNS INFLAMMATION

      European journal of neuroscience
    43. HOOPER DC; SPITSIN S; ZBOREK A; KOPROWSKI H
      EVIDENCE IMPLICATING PEROXYNITRITE (ONOO-) IN THE PATHOGENESIS OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS (EAE) AND MULTIPLE-SCLEROSIS (MS)

      The FASEB journal
    44. DIETZSCHOLD B; HOOPER DC
      HUMAN-DIPLOID CELL-CULTURE RABIES VACCINE (HDCV) AND PURIFIED CHICK-EMBRYO CELL-CULTURE RABIES VACCINE (PCECV) BOTH CONFER PROTECTIVE IMMUNITY AGAINST INFECTION WITH THE SILVER-HAIRED BAT RABIES VIRUS-STRAIN (SHBRV)

      Vaccine
    45. HOOPER DC
      CLINICAL-APPLICATIONS OF QUINOLONES

      Biochimica et biophysica acta, N. Gene structure and expression
    46. FRIDKIN SK; YOKOE DS; WHITNEY CG; ONDERDONK A; HOOPER DC
      EPIDEMIOLOGY OF A DOMINANT CLONAL STRAIN OF VANCOMYCIN-RESISTANT ENTEROCOCCUS-FAECIUM AT SEPARATE HOSPITALS IN BOSTON, MASSACHUSETTS

      Journal of clinical microbiology
    47. FOURNIER B; HOOPER DC
      EFFECTS OF MUTATIONS IN GRLA OF TOPOISOMERASE-IV FROM STAPHYLOCOCCUS-AUREUS ON QUINOLONE AND COUMARIN ACTIVITY

      Antimicrobial agents and chemotherapy
    48. FOURNIER B; HOOPER DC
      MUTATIONS IN TOPOISOMERASE-IV AND DNA GYRASE OF STAPHYLOCOCCUS-AUREUS- NOVEL PLEIOTROPIC EFFECTS AN QUINOLONE AND COUMARIN ACTIVITY

      Antimicrobial agents and chemotherapy
    49. YANG J; HOOPER DC; WUNNER WH; KOPROWSKI H; DIETZSCHOLD B; FU ZF
      THE SPECIFICITY OF RABIES VIRUS-RNA ENCAPSIDATION BY NUCLEOPROTEIN

      Virology
    50. MORIMOTO K; HOOPER DC; CARBAUGH H; FU ZF; KOPROWSKI H; DIETZSCHOLD B
      RABIES VIRUS QUASI-SPECIES - IMPLICATIONS FOR PATHOGENESIS

      Proceedings of the National Academy of Sciences of the United Statesof America
    51. MODELSKA A; DIETZSCHOLD B; SLEYSH N; FU ZF; STEPLEWSKI K; HOOPER DC; KOPROWSKI H; YUSIBOV V
      IMMUNIZATION AGAINST RABIES WITH PLANT-DERIVED ANTIGEN

      Proceedings of the National Academy of Sciences of the United Statesof America
    52. HOOPER DC; SPITSIN S; KEAN RB; CHAMPION JM; DICKSON GM; CHAUDHRY I; KOPROWSKI H
      URIC-ACID, A NATURAL SCAVENGER OF PEROXYNITRITE, IN EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS AND MULTIPLE-SCLEROSIS

      Proceedings of the National Academy of Sciences of the United Statesof America
    53. KONTOYIANNIS DP; RUOFF K; HOOPER DC
      NOCARDIA BACTEREMIA - REPORT OF 4 CASES AND REVIEW OF THE LITERATURE

      Medicine
    54. HOOPER DC; MORIMOTO K; BETTE M; WEIHE E; KOPROWSKI H; DIETZSCHOLD B
      COLLABORATION OF ANTIBODY AND INFLAMMATION IN CLEARANCE OF RABIES VIRUS FROM THE CENTRAL-NERVOUS-SYSTEM

      Journal of virology
    55. Hooper, DC
      Expanding uses of fluoroquinolones: Opportunities and challenges

      ANNALS OF INTERNAL MEDICINE
    56. NG EWM; SAMIY N; RUOFF KL; COUSINS FV; HOOPER DC; VONGUNTEN S; DAMICO DJ; BAKER AS
      TREATMENT OF EXPERIMENTAL STAPHYLOCOCCUS-EPIDERMIDIS ENDOPHTHALMITIS WITH ORAL TROVAFLOXACIN

      American journal of ophthalmology
    57. RICHT JA; ALEXANDER RC; HERZOG S; HOOPER DC; KEAN R; SPITSIN S; BECHTER K; SCHUTTLER R; FELDMANN H; HEISKE A; FU ZF; DIETZSCHOLD B; ROTT R; KOPROWSKI H
      FAILURE TO DETECT BORNA-DISEASE VIRUS-INFECTION IN PERIPHERAL-BLOOD LEUKOCYTES FROM HUMANS WITH PSYCHIATRIC-DISORDERS

      Journal of neurovirology
    58. SAMIY N; NG EWM; RUOFF KL; COUSINS FV; HOOPER DC; DAMICO DJ; BAKER AS
      TREATMENT OF EXPERIMENTAL STAPHYLOCOCCUS-EPIDERMIDIS ENDOPHTHALMITIS WITH ORAL TROVAFLOXACIN

      Investigative ophthalmology & visual science
    59. PEGUES DA; PEGUES CF; HIBBERD PL; FORD DS; HOOPER DC
      EMERGENCE AND DISSEMINATION OF A HIGHLY VANCOMYCIN-RESISTANT VANA STRAIN OF ENTEROCOCCUS-FAECIUM AT A LARGE TEACHING HOSPITAL

      Journal of clinical microbiology
    60. BISOGNANO C; VAUDAUX PE; LEW DP; NG EYW; HOOPER DC
      INCREASED EXPRESSION OF FIBRONECTIN-BINDING PROTEINS BY FLUOROQUINOLONE-RESISTANT STAPHYLOCOCCUS-AUREUS EXPOSED TO SUBINHIBITORY LEVELS OF CIPROFLOXACIN

      Antimicrobial agents and chemotherapy
    61. BREINES DM; OUABDESSELAM S; NG EY; TANKOVIC J; SHAH S; SOUSSY CJ; HOOPER DC
      QUINOLONE RESISTANCE LOCUS NFXD OF ESCHERICHIA-COLI IS A MUTANT ALLELE OF THE PARE GENE ENCODING A SUBUNIT OF TOPOISOMERASE-IV

      Antimicrobial agents and chemotherapy
    62. HOOPER DC; BAGASRA O; MARINI JC; ZBOREK A; OHNISHI ST; KEAN R; CHAMPION JM; SARKER AB; BOBROSKI L; FARBER JL; AKAIKE T; MAEDA H; KOPROWSKI H
      PREVENTION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS BY TARGETING NITRIC-OXIDE AND PEROXYNITRITE - IMPLICATIONS FOR THE TREATMENT OF MULTIPLE-SCLEROSIS

      Proceedings of the National Academy of Sciences of the United Statesof America
    63. YUSIBOV V; MODELSKA A; STEPLEWSKI K; AGADJANYAN M; WEINER D; HOOPER DC; KOPROWSKI H
      ANTIGENS PRODUCED IN PLANTS BY INFECTION WITH CHIMERIC PLANT-VIRUSES IMMUNIZE AGAINST RABIES VIRUS AND HIV-1

      Proceedings of the National Academy of Sciences of the United Statesof America
    64. PEGUES CF; PEGUES DA; FORD DS; HIBBERD PL; CARSON LA; RAINE CM; HOOPER DC
      BURKHOLDERIA CEPACIA RESPIRATORY-TRACT ACQUISITION - EPIDEMIOLOGY ANDMOLECULAR CHARACTERIZATION OF A LARGE NOSOCOMIAL OUTBREAK

      Epidemiology and infection
    65. MODELSKA A; DEBRUIN S; NOTIDIS E; KEAN R; CONWAY LJ; CARLSON PS; KOPROWSKI H; HOOPER DC
      TRANSGENIC PLANT ENDOPHYTIC BACTERIA AS VACCINE DELIVERY VEHICLES

      The FASEB journal
    66. CHEN NT; BUTLER PEM; HOOPER DC; MAY JW
      BACTERIAL-GROWTH IN SALINE IMPLANTS - IN-VITRO AND IN-VIVO STUDIES

      Annals of plastic surgery
    67. NG EWM; SAMIY N; RUOFF K; PATON B; HOOPER DC; DAMICO DJ; BAKER AS
      OCULAR PHARMACOKINETICS OF ORAL CP-99,219 IN A RABBIT MODEL OF STAPHYLOCOCCUS-EPIDERMIDIS ENDOPHTHALMITIS

      Investigative ophthalmology & visual science
    68. NG EY; TRUCKSIS M; HOOPER DC
      QUINOLONE RESISTANCE MUTATIONS IN TOPOISOMERASE-IV - RELATIONSHIP TO THE FLQA LOCUS AND GENETIC-EVIDENCE THAT TOPOISOMERASE-IV IS THE PRIMARY TARGET AND DNA GYRASE IS THE SECONDARY TARGET OF FLUOROQUINOLONES IN STAPHYLOCOCCUS-AUREUS

      Antimicrobial agents and chemotherapy
    69. MORIMOTO K; HOOPER DC; BORNHORST A; CORISDEO S; BETTE M; FU ZF; SCHAFER MKH; KOPROWSKI H; WEIHE E; DIETZSCHOLD B
      INTRINSIC RESPONSES TO BORNA-DISEASE VIRUS-INFECTION OF THE CENTRAL-NERVOUS-SYSTEM

      Proceedings of the National Academy of Sciences of the United Statesof America
    70. MORIMOTO K; PATEL M; CORISDEO S; HOOPER DC; FU ZF; RUPPRECHT CE; KOPROWSKI H; DIETZSCHOLD B
      CHARACTERIZATION OF A UNIQUE VARIANT OF BAT RABIES VIRUS RESPONSIBLE FOR NEWLY EMERGING HUMAN CASES IN NORTH-AMERICA

      Proceedings of the National Academy of Sciences of the United Statesof America
    71. MCGARVEY PB; HAMMOND J; DIENELT MM; HOOPER DC; FU ZF; DIETZSCHOLD B; KOPROWSKI H; MICHAELS FH
      EXPRESSION OF THE RABIES VIRUS GLYCOPROTEIN IN TRANSGENIC TOMATOES

      Bio/technology
    72. CEBRA JJ; BOS NA; HOOPER DC; KRAMER DR; LEE F; SHROFF KE
      THE DEVELOPMENT AND MAINTENANCE OF THE NORMAL STEADY-STATE OF GALT INNEONATES AND FORMERLY GERM-FREE MICE MAY BE DRIVEN DIFFERENTIALLY BY VARIOUS COMMENSAL ENTERIC BACTERIA AND ENTERIC VIRUSES

      Journal of cellular biochemistry
    73. TRUONG QC; OUABDESSELAM S; HOOPER DC; MOREAU NJ; SOUSSY CJ
      SEQUENTIAL MUTATIONS OF GYRA IN ESCHERICHIA-COLI ASSOCIATED WITH QUINOLONE THERAPY

      Journal of antimicrobial chemotherapy
    74. HOOPER DC
      2-PYRIDONES - REPLY

      Lancet
    75. HOOPER DC
      FROM FLUOROQUINOLONES TO 2-PYRIDONES

      Lancet
    76. OUABDESSELAM S; HOOPER DC; TANKOVIC J; SOUSSY CJ
      DETECTION OF GYRA AND GYRB MUTATIONS IN QUINOLONE-RESISTANT CLINICAL ISOLATES OF ESCHERICHIA-COLI BY SINGLE-STRAND CONFORMATIONAL POLYMORPHISM ANALYSIS AND DETERMINATION OF LEVELS OF RESISTANCE CONFERRED BY 2 DIFFERENT SINGLE GYRA MUTATIONS

      Antimicrobial agents and chemotherapy
    77. HOOPER DC; OHNISHI ST; KEAN R; NUMAGAMI Y; DIETZSCHOLD B; KOPROWSKI H
      LOCAL NITRIC-OXIDE PRODUCTION IN VIRAL AND AUTOIMMUNE-DISEASES OF THECENTRAL-NERVOUS-SYSTEM

      Proceedings of the National Academy of Sciences of the United Statesof America
    78. DIETZSCHOLD B; SCHWAEBLE W; SCHAFER MKH; HOOPER DC; ZEHNG YM; PETRY F; SHENG H; FINK T; LOOS M; KOPROWSKI H; WEIHE E
      EXPRESSION OF C1Q, A SUBCOMPONENT OF THE RAT COMPLEMENT-SYSTEM, IS DRAMATICALLY ENHANCED IN BRAINS OF RATS WITH EITHER BORNA-DISEASE OR EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS

      Journal of the neurological sciences
    79. HOOPER DC; MOLOWITZ EH; BOS NA; PLOPLIS VA; CEBRA JJ
      SPLEEN-CELLS FROM ANTIGEN-MINIMIZED MICE ARE SUPERIOR TO SPLEEN-CELLSFROM GERM-FREE AND CONVENTIONAL MICE IN THE STIMULATION OF PRIMARY IN-VITRO PROLIFERATIVE RESPONSES TO NOMINAL ANTIGENS

      European Journal of Immunology
    80. PHILLIPS I; HOOPER DC; PERCIVAL A; SMITH T; THORNSBERRY C; WISE R
      QUINOLONE RESISTANCE IN GRAM-NEGATIVE BACTERIA - PANEL DISCUSSION

      Infectious diseases in clinical practice
    81. HOOPER DC; RUBIN DH; CEBRA JJ
      SPONTANEOUS PROLIFERATION OF PEYERS PATCH CELLS IN-VITRO

      International immunology
    82. NG EYW; TRUCKSIS M; HOOPER DC
      QUINOLONE RESISTANCE MEDIATED BY NORA - PHYSIOLOGICAL CHARACTERIZATION AND RELATIONSHIP TO FLQB, A QUINOLONE RESISTANCE LOCUS ON THE STAPHYLOCOCCUS-AUREUS CHROMOSOME

      Antimicrobial agents and chemotherapy
    83. HOOPER DC; PIERARD I; MODELSKA A; OTVOS L; FU ZF; KOPROWSKI H; DIETZSCHOLD B
      RABIES RIBONUCLEOCAPSID AS AN ORAL IMMUNOGEN AND IMMUNOLOGICAL ENHANCER

      Proceedings of the National Academy of Sciences of the United Statesof America
    84. SOUSSY CJ; WOLFSON JS; NG EY; HOOPER DC
      LIMITATIONS OF PLASMID COMPLEMENTATION TEST FOR DETERMINATION OF QUINOLONE RESISTANCE DUE TO CHANGES IN THE GYRASE A PROTEIN AND IDENTIFICATION OF CONDITIONAL QUINOLONE RESISTANCE LOCUS

      Antimicrobial agents and chemotherapy
    85. CHEN NT; HONG HZ; HOOPER DC; MAY JW
      EFFECT OF SYSTEMIC ANTIBIOTIC AND ANTIBIOTIC-IMPREGNATED POLYMETHYLMETHACRYLATE BEADS ON THE BACTERIAL CLEARANCE IN WOUNDS CONTAINING CONTAMINATED DEAD BONE

      Plastic and reconstructive surgery
    86. YOUNG JL; HOOPER DC
      CHARACTERIZATION OF AUTOREACTIVE HELPER T-CELLS IN A MURINE MODEL OF AUTOIMMUNE HEMOLYTIC-DISEASE

      Immunology
    87. FAHY GT; HOOPER DC; EASTY DL
      ANTIGEN PRESENTATION OF HERPES-SIMPLEX VIRUS BY CORNEAL EPITHELIUM - AN IN-VITRO AND IN-VIVO STUDY

      British journal of ophthalmology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/01/21 alle ore 19:08:52